dataBioavailability well absorbedProtein binding 96%Metabolism casodex for eary stage prostate cancer life 5.8 daysExcretion ?Therapeutic considerationsPregnancy cat. X(US)Legal status ? Prescription onlyRoutes OralBicalutamide (marketed as Casodex®, casodex for eary stage prostate cancer Calutide®, Kalumid®) is an oral non-steroidal anti-androgen with the brand names.

Leuprorelin, Nafarelin, casodex for eary stage prostate cancer Abarelix, Cetrorelix, Ganirelix BicalutamideFrom Wikipedia, the free encyclopedia(Redirected from Casodex)Jump to: navigation, searchBicalutamideSystematic (IUPAC) nameN-[4-cyano-3-(trifluoromethyl)phenyl]- 3-(4-fluorophenyl)sulfonyl-2- hydroxy-2-methyl- casodex for eary stage prostate cancer number 90357-06-5ATC casodex for eary stage prostate cancer L02BB03PubChem 56069DrugBank APRD00042Chemical dataFormula C18H14F4N2O4SMol. mass 430.374 g/molPharmacokinetic dataBioavailability well absorbedProtein binding 96%Metabolism hepaticHalf life 5.8 daysExcretion ?Therapeutic considerationsPregnancy cat. X(US)Legal status ? Prescription onlyRoutes OralBicalutamide (marketed as Casodex®, Cosudex®, Calutide®, Kalumid®) is an off-white powder that is practically insoluble in water.[edit] Indications casodex for eary stage prostate cancer useFor the treatment of earlier stages of the disease.It is marketed by AstraZeneca with the empirical casodex for eary stage prostate cancer C18H14N2O4F4S and is an oral non-steroidal anti-androgen with the empirical formula.

Levonorgestrel, Lynestrenol, Medroxyprogesterone, Megestrol, Norelgestromin, Norethisterone, Norethynodrel.